GW Pharmaceuticals and GNC met with White House on CBD
One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.
FDA expands outreach on CBD • Congress: new bill to allow disaster relief for cannabis • UK: clarity on cannabis stocks • & more…
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
South Dakota: Citing Arrest Data, Advocates Push on Dual Medical, Adult Use Initiatives
This November, for the first time, a state’s voters will see both medical and adult use on their November ballots. One in ten arrests in the state are for cannabis, a new report found.
Colorado sales spike continues • Connecticut’s cannabis potential • New Mexico gov calls for legalization amid COVID-19 • & more…
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
US cannabis use on the rise • Vermont House OKs cannabis sales • Arizona poll shows slim legalization support • & more…
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Cannabis in Congress: The MORE Act Vote Will Be Delayed
Supporters of the bill to remove cannabis from the Controlled Substances Act expressed frustration and disappointment.
Vermont Lawmakers Reach Deal on Cannabis Sales
A conference committee of key House and Senate lawmakers have found common ground on cannabis sales, meaning a regulated market might soon be coming to Vermont.
Deep-dive: Cannabis Pilot Programs Are Sprouting in Europe
In various ways, and in various nations, leaders are looking for ways to clean up the illicit market or try out medical use.
Los Angeles Deputy DA: California Illicit Cannabis Is “Worst of Any State That Has Legalized”
As the California Cannabis Control Summit wrapped, illegal cannabis cultivation and storefronts remained top-of-mind for many California cannabis regulators and officials.
Australia’s interim CBD decision • Jamaica wants cannabis banking fix • GW Pharma pushes on MS in US • & more…
An excerpt from recent editions of the Cannabis Wire Daily newsletter.